ロード中...
Factor XI deficiency diagnosed following use of adalimumab
Adalimumab is a drug used in the treatment of refractory psoriasis. We present a case of a 55-year-old male patient who developed petechiae and purpura after the ninth dose of adalimumab therapy. The results of laboratory investigations revealed factor XI (F.XI) deficiency. It should be recognized t...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4175897/ https://ncbi.nlm.nih.gov/pubmed/25298590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.140596 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|